Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial - Concepedia

Concepedia

Publication | Open Access

Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial

DOI Full Paper Access

75

Citations

33

References

2015

Year

A. Seferian, A. Moraux, M. Annoussamy, Aurélie Canal, V. Decostre, Oumar Diebate, Anne‐Gaëlle Le Moing, Teresa Gidaro, Nicolas Deconinck, F. Van Parys,

Abstract

ClinicalTrials.gov NCT00993161 NCT00993161.

References

	Year	Citations
ATS Statement American Journal of Respiratory and Critical Care Medicine	2002	10.5K
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management K. Bushby, Richard S. Finkel, David J. Birnkrant, The Lancet Neurology Part 1KinesiologyPsychiatryDuchenne Muscular DystrophyDegenerative Disease	2009	2K
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri, The Lancet Exon SkippingUrologyDuchenne Muscular DystrophyPhase 2Medicine	2011	852
Eteplirsen for the treatment of Duchenne muscular dystrophy Jerry R. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk, Annals of Neurology	2013	770
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy Nathalie Goemans, M. Tulinius, Johanna T. van den Akker, New England Journal of Medicine	2011	659
Muscular dystrophies Eugenio Mercuri, Francesco Muntoni The Lancet	2013	412
The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy Craig M. McDonald, Erik Henricson, Jay J. Han, Muscle & Nerve	2009	386
Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy Oona M. Scott, Stephanie Hyde, C. Goddard, Muscle & Nerve	1982	296
THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study Craig M. McDonald, Erik Henricson, Richard T. Abresch, Muscle & Nerve	2013	295
The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures Erik Henricson, Richard T. Abresch, Avital Cnaan, Muscle & Nerve	2013	197

Page 1